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Abstract
In the ‘older’ literature, a definitive renal pathology was described in patients with long-standing hypokalaemia and depletion
of the body’s potassium reserves. The topic is relevant because possibly a quite cheaply reversible element in the course of
chronic kidney disease progression could be addressed. Earlier, pathologists drew attention to vacuolar changes in renal tubular
epithelium accompanied by inflammatory interstitial changes in patientswith potassium losses. The diagnostic term ‘kaliopenic
nephropathy’ was coined to describe such patients. Kaliopenic nephropathy now receives less emphasis than in earlier times.
However, with eating disorders, laxative abuse and other potential causes, we suggest that the syndrome should be resurrected.
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Introduction
Kaliopenic nephropathy seems largely to have disappeared.
Bock et al. [1] described 23 chronically hypokalaemic patients,
21 women, that they followed up for >6 years (not quite) 40
years ago. The causes of hypokalaemia were malnutrition, laxa-
tive abuse, self-administered diuretic usage or a combination of
these factors. The authors biopsied nine patients and found
interstitial nephritis and tubular vacuolization. Gradually over
time, renal function deteriorated in many of these patients;
they progressed to chronic kidney disease (CKD). Since they
were seldom convinced to alter their behaviours, the authors
favoured a diagnosis of chronic kaliopenic nephropathy. A simi-
lar condition was described in cats; in the felines, dietary rather
than behavioural or drug-related problemsweremore prominent
[2]. A recent patient caused us to revisit this syndrome.
The case
A 58-year-old woman was referred to us because of weakness
and chronic generalized pain ‘all over’. She lived in a wealthy
Middle Eastern country. She claimed chronic weight loss over
the past 2 years that she could not explain. Her physician
had prescribed methotrexate for ‘rheumatoid factor-negative’
rheumatoid arthritis; however, we could not identify any clinical
correlates of this condition. With additional questioning, she ad-
mitted to having ingested laxatives (currently bisacodyl) for years
because of ‘bloating’, abdominal distension and various discom-
forts. She chronically ingested acetaminophen and non-steroidal
anti-inflammatory drugs for pain, but denied diuretic ingestion.
As far as we could discern, she had practically stopped eating
altogether. On examination, she appeared in Western dress.
The blood pressure was 100/60 mmHg, heart rate 76 bpm, she
was afebrile, weighed 44 kg and had a body mass index (weight
kg/height m2) of 17.2. She had no evidence of rheumatoid arth-
ritis or any other chronic medical condition aside from cachexia
on physical examination. She had no oedema.
Routine laboratory and imagingworkup revealed haemoglobin
of 8.2 g/dL and haematocrit 25 vol%; the anaemiawas normochro-
mic, normocytic (MCV86 fL,MCH29.6 pgandMCHC34.4 g/dL). She
hadnormal platelets (326 Gpt/L) andnormal leucocytes (6.4 Gpt/L).
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The sodiumwas 138, potassium2.9, calcium2.4 andphosphate 0.4
(allmmol/L). The creatininewas 157 µmol/L.We used cystatin C to
estimate the glomerular filtration rate (GFR) at 15mol/min. The 25-
OHvitaminD3was9.6 µg/L (normal >30 µg/L) and 1,25-OHvitamin
D3 was 11.0 ng/L (normal 25–60 ng/L). The parathyroid hormone
concentrationwas 1.68 pmol/L (normal 1.6–6.9 pmol/L). Bone alka-
line phosphatase was 62.4 µg/L, which is high, (upper limit of the
norm, 24.4 µg/l). Urinalysis showed some white and red blood
cells, but no remarkable elements. The protein:creatinine ratio
was 436 mg/g, while the albumin:creatinine ratio was 26 mg/g
(slightly elevated). A capillary blood sample revealed a pH of 7.29,
PaCO2 31, PaO2 75 (both mmHg) and bicarbonate 14 mmol/L. Vari-
ous antibody tests for chronic systemic illnesseswerenegative.We
collected urine for 24 h. Here, the sodium excretion was 48, potas-
sium14.4 and phosphate 0.7 (allmmol/L). Ultrasound studieswere
normal and the gastroscopy showed signs of oesophageal candid-
iasis. Our gastroenterologist consultant performed a requested
colonoscopy. He had not been forewarned but nonetheless
thought that the colon showed signs of pseudomelanosis coli
and performed a biopsy (Figure 1 ). The specimen confirmed the
presence of lipofuscin-laden macrophages.
Since the patient had estimated GFR (eGFR) of 15 mL/min, we
performed a renal biopsy (Figure 2). The glomeruli were normal
(Figure 2A). Interstitial oedema and round-cell infiltrates were
present (Figure 2B). Tubules were filled with hyalinaceous casts.
Small vessel fibrosis was observed (Figure 2C). However, the in-
variable and striking feature was vacuolization of the renal tubu-
lar epithelium that could be observed in almost every section in
both proximal and distal renal tubular epithelium (Figure 2D).We
also performed a bone biopsy that disclosed a picture consistent
with vitamin D deficiency, namely osteomalacia, and osteopor-
osis (not shown). We tested for renal tubular acidosis and found
that our patient could acidify her urine normally.We did not spe-
cifically test her urinary concentrating ability.
Our treatment programmewas dietetic—‘we fed her’. She ap-
peared to cooperate and did not develop symptoms of refeeding
[3]. The patient resided in a private, luxurious ward and all her
wishes were answered. She was pleasant and gracious towards
all clinical questions, although the answers did not invariably
satisfy clinical nosiness. Finally, we could not discern how she
dressed in her home environment since this state of affairs
could clearly have influenced her bone metabolism. Over the
ensuingmonth that she stayedwith us, the hypokalaemia, hypo-
phosphataemia and even the metabolic acidosis went away.
We stopped the methotrexate. We never found a specific ‘cause’
of our patient’s problems. However, under close observation,
careful control of surreptitious medications and hospital food,
the clinical picture reverted to normal and she gained 7 kg in
weight. She travelled back to her country of origin with avuncular
advice from us, but with a guarded prognosis nonetheless.
Discussion
We concluded that laxative abuse and self-imposedmalnutrition
lay at the heart of our patient’s problems. Virchow is responsible
for themisnomer,melanosis coli [4]. The colonic pigmentation is
triggered by deposits of apoptotic cells, which are ingested by ad-
jacentmacrophageswithin the epithelial tissue [5]. Thosemacro-
phages migrate in the lamina propria, where lysosomes convert
the remains of the cells into lipofuscin pigment. Thus, the term
‘melanosis’ is misleading, since the pigment is not melanin.
We used the term ‘pseudomelanosis’here. In addition to its asso-
ciation with anthraquinones, pseudomelanosis coli may appear
during long-term bisacodyl administration.
Our patient did not have classic manifestations of anorexia
nervosa, although similar to those patients, her condition was
self-inflicted. Anorexia nervosa can affect the kidney in numer-
ous ways, including increased rates of acute kidney injury (AKI)
and CKD, electrolyte abnormalities and nephrolithiasis [6]. In
anorexia nervosa, there are limitations of serum creatinine
level in estimating kidney function, which caused us to rely on
cystatin C estimates. Furthermore, the psychosocial challenges
inherent with treating systemic manifestations of psychiatric
conditions in anorexia nervosa patients are well appreciated.
We expect that those in our patient will be little different.
We could identify no renal disease that could explain our pa-
tient’s symptom constellation, although she clearly had one. An
eGFR of 15 mL/min has no trivial connotations. She had intersti-
tial renal disease that could have various explanations. However,
the dominant histological finding was the intense vacuolariza-
tion of the renal tubular epithelium. Renal tubular vacuoles are
nothing new. We were interested to review the report by Jaffé
and Sternberg [7], who, to our knowledge, were the first to de-
scribe vacuolarization in renal tubular cells after hypokalaemia.
Clinicians at that time could not measure potassium. However,
they were aware of diarrhoea. Renal biopsies were not done
then, so the authors relied on autopsies performed on chronic
diarrhoea victims. The disease conditions in their patients lasted
between 6 and 21weeks. The histology shown in their paper, also
with haematoxylin and eosin staining, is very similar to the sec-
tions we display here. The authors concluded that vacuolar de-
generation of renal epithelium could represent an important
avenue for investigating renal diseases in general. After all,
fatty, hyaline droplets, amyloid degenerations, cloudy swelling,
etc. appear in all CKD-related processes.
Riemenschneider and Bohle [8] also investigated renal
morphology in patients with kaliopenic nephropathy. They re-
viewed renal biopsies from 40 patients with hypokalaemia and
hyponatraemia of an average of 10-years duration due to laxative
or diuretic abuse, anorexia nervosa or chronic vomiting. Lightmi-
croscopy revealed juxtaglomerular cells that were sometimes
enormously enlarged. In their series, the proximal and distal tu-
bules contained non-specific vacuoles in only 8 of 40 biopsy spe-
cimens. In 75% of the cases, the interstitial surface area was
increasedwith predominantly focal lymphocytic cellular infiltra-
tion. Interstitial fibrosis was pronounced in emaciated patients.
The pathological changes of kaliopenic nephropathy have been
modelled in rats. Sarkar and Levine [9] found that the renal tubu-
lar epithelial cells showed electron-lucent vacuoles, lysosome-
like dense bodies, focal cytoplasmic degradation and dilated
Fig. 1. Normal-appearing colonic epithelium is seen with lipofuscin-laden
macrophages residing under the mucous layer.





























intercellular spaces in many proximal tubules. They also de-
scribed medullary cell droplets with sequestration of cytoplas-
mic components.
Recently, Reungjui et al. [10] drew attention to the fact that
hypokalaemic nephropathy is associated with angiogenesis.
They found that Sprague Dawley rats fed low-potassiumdiets de-
veloped peritubular capillary loss. These changes were associated
with increased macrophage infiltration, increased expression of
both monocyte chemoattractant protein-1 and tumour necrosis
factor alpha and a loss of vascular endothelial growth factor
(VEGF) and endothelial nitric oxide synthase. Renal markers of
oxidative stress were increased late in the disease. The authors
concluded that hypokalaemic nephropathy is associated with
impaired renal angiogenesis, evidenced by progressive capillary
loss, reduced endothelial cell proliferation and loss of VEGF ex-
pression. These mechanisms could clearly have played a role in
our patient.
Kaliopenic nephropathy could have additional consequences
[11]. Resistance to vasopressin has been described by increased
prostaglandin production that inhibits adenylate cyclase produc-
tion in response to vasopressin. In addition to the droplet accu-
mulation, hyperplastic epithelial cells are a feature that could
contribute to cyst formation [12]. Torres et al. [13] reported on
the occurrence of reversible, medullary renal cysts in patients
with chronic potassium depletion. We could identify no such
cysts in our patient.
Potassium homeostasis has recently been extensively
reviewed [14]. A case example from that review concerns a pa-
tient with Gitelman’s syndrome, a genetic cause for chronic
hypokalaemia that should engender kaliopenic nephropathy.
Interestingly, we found few examples of Gitelman’s syndrome
and hypokalaemic nephropathy. A renal biopsy from an isolated
case with renal insufficiency disclosed severe interstitial
nephritis, but without the prominent droplet lesions exhibited
by our patient [15]. In this condition, total body magnesium de-
pletion may also contribute to nephropathy.
Twenty-four hour urinary sodium and potassium excretion is
used to assess intake of these electrolytes. Conceivably, a high-
sodium intake and a low potassium intake, perhaps by hypokal-
aemia-related renal injury, could influence the course of chronic
renal disease. Investigators prospectively studied the association
of urinary sodium and potassium excretion with CKD progres-
sion and all-cause mortality among 3939 patients with CKD in
the Chronic Renal Insufficiency Cohort Study. Urinary sodium
and potassium excretion was measured using three 24-h urine
specimens, and CKD progression was defined as incident end-
stage renal disease or halving of eGFR [16]. True to the prediction,
the highest quartile of sodium excretion had a relative risk for
progression of 1.54. However, similar results were obtained
for the quartiles of potassium excretion. The finding that high
urinary potassium excretion was significantly and independent-
ly associated with an increased risk of CKD progression was
unexpected and remains inadequately explained.
An additional issue could be that total body potassium deple-
tion and hypokalaemia could increase the risk of AKI. In isolated
case reports, clinicians have postulated a contributory role of
hypokalaemia involved in the pathophysiology of renal ischae-
mia-induced AKI, althoughmechanisms have not been provided
[17]. Here, animal models could be elucidating.
Wewere surprised that little has been learnedmechanistically
about hypokalaemia and the increased risk of CKD. Since cats
seem particularly subject to CKD when they develop hypokal-
aemia, perhaps they could become an appropriate animal
model. Dow et al. [18] found that within a group of 186 hypo-
kalaemic cats, high serum urea nitrogen concentrations, hyper-
chloraemia and high serum creatinine concentrations were the
Fig. 2. (A) Normal glomerulus, several proximal tubules with widespread vacuolization and some hyaline casts. (B) Dense lymphocytic interstitial infiltrate, hyaline casts































most common biochemical abnormalities. When disease diagno-
sis was compared among cats with severe hypokalaemia (serum
potassium concentration <3.0 mmol/L) and those with moderate
hypokalaemia, cats with severe hypokalaemia were 3.5 times
more likely to have CKD than cats with less severe hypokalaemia.
Unfortunately, the authors could provide no biopsy data.
Despite the fact that the term kaliopenic nephropathy has
disappeared from the literature in the last 20 years, we believe
the condition still exists. Perhaps we are dealing with a semantic
definition. The term hypokalaemic nephropathy with CKD is
found more often. A hypokalaemic patient with an aldoster-
one-producing tumour was reported, but that patient exhibited
tubulointerstitial injury [19]. Nevertheless, eating and laxative
disorders as exhibited by our patient remain important in the
pathogenesis of chronic renal disease [20].
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